Hims & Hers Health (HIMS) Accumulated Expenses (2019 - 2026)
Hims & Hers Health's (HIMS) quarterly Accumulated Expenses came in at $90.7 million in Q1 2026, up 59.36% year-on-year from $56.9 million in Q1 2025, and up 15.57% quarter-over-quarter from $78.5 million in Q4 2025.
Hims & Hers Health (HIMS) Accumulated Expenses (2019 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Accumulated Expenses across 8 years of filings, most recently posting $90.7 million for Q1 2026.
- Accumulated Expenses for Q1 2026 came in at $90.7 million, up 59.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $90.7 million (up 59.36% YoY), and the FY2025 annual result was $78.5 million, up 48.11% from the prior year.
- Accumulated Expenses came in at $90.7 million for Q1 2026 at Hims & Hers Health, up from $78.5 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $90.7 million in Q1 2026 to a low of $9.1 million in Q1 2022.
- The 5-year median for Accumulated Expenses is $28.9 million (2024), against an average of $39.1 million.
- Across the five-year window, Accumulated Expenses rose 2.08% in 2022 and surged 132.74% in 2023, its largest moves.
- Hims & Hers Health's Accumulated Expenses stood at $12.4 million in 2022, then soared by 132.74% to $29.0 million in 2023, then surged by 82.98% to $53.0 million in 2024, then surged by 48.11% to $78.5 million in 2025, then increased by 15.57% to $90.7 million in 2026.
- The last three Accumulated Expenses figures came in at $90.7 million (Q1 2026), $78.5 million (Q4 2025), and $80.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn |
| 10 | Hims & Hers Health | 6.15 Bn | 5.40 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 90.74 Mn |
| Dec 31, 2025 | 78.52 Mn |
| Sep 30, 2025 | 80.13 Mn |
| Jun 30, 2025 | 65.67 Mn |
| Mar 31, 2025 | 56.94 Mn |
| Dec 31, 2024 | 53.01 Mn |
| Sep 30, 2024 | 43.22 Mn |
| Jun 30, 2024 | 28.95 Mn |
| Mar 31, 2024 | 26.71 Mn |
| Dec 31, 2023 | 28.97 Mn |
| Sep 30, 2023 | 27.36 Mn |
| Jun 30, 2023 | 19.61 Mn |
| Mar 31, 2023 | 14.12 Mn |
| Dec 31, 2022 | 12.45 Mn |
| Sep 30, 2022 | 17.15 Mn |
| Jun 30, 2022 | 11.81 Mn |
| Mar 31, 2022 | 9.09 Mn |
| Dec 31, 2021 | 12.19 Mn |
| Sep 30, 2021 | 11.21 Mn |
| Jun 30, 2021 | 10.76 Mn |